GRSF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.875600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.721620E-01
Normal-vs-Stage2
5.232400E-01
Normal-vs-Stage3
9.009400E-01
Normal-vs-Stage4
3.733000E-01
Stage1-vs-Stage2
9.229900E-02
Stage1-vs-Stage3
1.443380E-01
Stage1-vs-Stage4
8.285400E-01
Stage2-vs-Stage3
3.721200E-01
Stage2-vs-Stage4
3.115800E-01
Stage3-vs-Stage4
3.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.854000E-01
Normal-vs-AfricanAmerican
6.031400E-01
Normal-vs-Asian
7.079800E-01
Caucasian-vs-AfricanAmerican
7.128000E-01
Caucasian-vs-Asian
6.853700E-02
AfricanAmerican-vs-Asian
6.606400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.404600E-01
Normal-vs-Female
4.552400E-01
Male-vs-Female
8.430400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.232800E-01
Normal-vs-Age(41-60Yrs)
3.109000E-01
Normal-vs-Age(61-80Yrs)
7.176800E-01
Normal-vs-Age(81-100Yrs)
7.162400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.903200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.954000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.368400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.041770E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.372400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.018400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.599000E-01
Normal-vs-Daily Drinker
6.417200E-01
Normal-vs-Weekly Drinker
7.386400E-01
Normal-vs-Occasional Drinker
2.111200E-01
Normal-vs-Social Drinker
4.467000E-01
Non Drinker-vs-Daily Drinker
7.402400E-01
Non Drinker-vs-Weekly Drinker
9.347200E-01
Non Drinker-vs-Occasional Drinker
1.498240E-02
Non Drinker-vs-Social Drinker
1.951610E-01
Daily Drinker-vs-Weekly Drinker
7.045600E-01
Daily Drinker-vs-Occasional Drinker
2.442000E-02
Daily Drinker-vs-Social Drinker
2.625000E-01
Weekly Drinker-vs-Occasional Drinker
1.429860E-02
Weekly Drinker-vs-Social Drinker
1.851840E-01
Occasional Drinker-vs-Social Drinker
4.095400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.844600E-01
Normal-vs-Grade 2
6.316400E-01
Normal-vs-Grade 3
6.098200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.092800E-01
Grade 1-vs-Grade 3
2.575200E-01
Grade 1-vs-Grade 4
4.844600E-01
Grade 2-vs-Grade 3
5.938800E-01
Grade 2-vs-Grade 4
6.316400E-01
Grade 3-vs-Grade 4
6.098200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.764800E-01
Normal-vs-NonDiabetic
6.038200E-01
Diabetic-vs-NonDiabetic
3.776200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.789600E-01
Normal-vs-NoPancreatitis
6.137000E-01
Pancreatitis-vs-NoPancreatitis
5.404200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.706400E-02
Normal-vs-N1
4.947200E-01
N0-vs-N1
2.435400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.462620E-01
Normal-vs-TP53-NonMutant
2.244500E-02
TP53-Mutant-vs-TP53-NonMutant
4.039600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
